IGF-1 LR3 is a modified IGF-1 with an extended amino acid sequence that has 13 additional amino acids at the N-terminus and a substitution of arginine for glutamic acid at position 3
The clinical significance for GHK-Cu users is speculative but biochemically plausible
Supports healthy cardiovascular functioning
This article was previously distributed in the August 22, 2023, educational email of the Patient Safety Authority, available at About the Author Patient Safety Authority (patientsafety.pa.gov) is an independent state agency that oversees the Pennsylvania Patient Safety Reporting System (PA-PSRS), the largest database of its kind in the United States.
Nikiforov, A., Dlle, C., Niere, M
Similar content being viewed by others Introduction In line with the global epidemic of obesity and type 2 diabetes mellitus (T2DM) the prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing throughout the world